Dai Ichi Life Insurance Company, LTD Alnylam Pharmaceuticals, Inc. Transaction History
Dai Ichi Life Insurance Company, LTD
- $3.9 Billion
- Q3 2024
A detailed history of Dai Ichi Life Insurance Company, LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Dai Ichi Life Insurance Company, LTD holds 955 shares of ALNY stock, worth $222,658. This represents 0.01% of its overall portfolio holdings.
Number of Shares
955
Previous 1,077
11.33%
Holding current value
$222,658
Previous $261,000
0.38%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ALNY
# of Institutions
644Shares Held
109MCall Options Held
1.28MPut Options Held
1.21M-
Capital World Investors Los Angeles, CA16.5MShares$3.85 Billion0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.6MShares$2.95 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.23 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.24MShares$1.22 Billion0.31% of portfolio
-
Wellington Management Group LLP Boston, MA4.95MShares$1.15 Billion0.24% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $28.7B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...